There are currently 5 clinical trials in Fort Pierce, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Midway Immunology and Research Center, GSK Investigational Site and Midway Immunology & Research Center, LLC. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of GS-3242 in Participants With HIV-1
NCT07001319
Recruiting
This study is part of a master study. The goal of master protocol (GS-US-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Substudy GS-US-544-5905-05 is to learn more about the study drug GS-3242 in PWH.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/20/2025
Locations: Midway Immunology & Research Center, LLC, Fort Pierce, Florida
Conditions: HIV-1-infection
Register for Updates
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
NCT07047716
Recruiting
The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the body of the participants) of once-yearly intramuscular for HIV pre-exposure prophylaxis (PrEP) in people with an indication for PrEP. The primary objective of this study is to evaluate the pharmacokinetics (PK) and the safety and tolerability of intramuscular (IM) every 12 months (Q12M) LEN for PrEP... Read More
Gender:
ALL
Ages:
16 years and above
Trial Updated:
08/14/2025
Locations: Midway Immunology and Research Center, Fort Pierce, Florida
Conditions: HIV Pre-exposure Prophylaxis
Register for Updates
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
NCT07053384
Recruiting
This study investigates the use of VH3810109 with or without FTR to reduce the size and activity of the HIV viral reservoir in two sub-populations of people living with HIV: treatment-naïve adults (Population 1) and treatment-experienced adults currently taking a standard of care (SOC) integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) regimen (Population 2).
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
08/06/2025
Locations: GSK Investigational Site, Fort Pierce, Florida
Conditions: HIV Infections
Register for Updates
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
NCT06868264
Recruiting
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
07/23/2025
Locations: Atea Study Site, Fort Pierce, Florida
Conditions: HEPATITIS C VIRUS CHRONIC INFECTION
Register for Updates
A Clinical Trial of STP0404 in Adults With HIV-1 Infection
NCT05869643
Recruiting
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infection.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
05/08/2025
Locations: Midway Immunology and Research Center, Fort Pierce, Florida
Conditions: HIV-1-infection
Register for Updates